Track topics on Twitter Track topics that are important to you
Suite 1002, W2 Oriental Plaza
Phone: (8610) 8518 3088
Fax: (8610) 8518 3288
With Ascletis leading the way onto HKEX, market watchers wait and see whether investor enthusiasm for biotech can maintain momentum.
Having broken the seal on HKEX’s new biotech chapter, Ascletis’ performance could make or shake investor confidence in the sector.
BEIJING, Aug. 26, 2018 /PRNewswire/ -- China Petroleum & Chemical Corporation ("Sinopec" or the "Company")(HKEX: 386; SSE: 600028; NYSE: SNP) today announced its interim results Read more...
HONGKONG, 31. August 2018 /PRNewswire/ -- Air China Limited („Air China" oder „Unternehmen", zusammen mit seinen Tochtergesellschaften „Gruppe" genannt) (HKEX: 00753; LSE: AIRC; SSE: 601111: Re...
SUZHOU, China, Nov. 9, 2018 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 1801), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, ...
We have published hundreds of HKEx corparate news stories on BioPortfolio along with dozens of HKEx corparate Clinical Trials and PubMed Articles about HKEx corparate for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HKEx corparate Companies in our database. You can also find out about relevant HKEx corparate Drugs and Medications on this site too.